- Home
- CTSH vs IQV Comparison
CTSH vs IQV Comparison
Compare CTSH & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CTSH | IQV |
|---|---|---|
| Founded | 1994 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.3B | 36.4B |
| IPO Year | 1998 | 2013 |
Fundamental Metrics
Financial Performance| Metric | CTSH | IQV |
|---|---|---|
| Price | $84.38 | $224.13 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 17 |
| Target Price | $86.07 | ★ $237.59 |
| AVG Volume (30 Days) | ★ 4.6M | 1.4M |
| Earning Date | 02-04-2026 | 02-05-2026 |
| Dividend Yield | ★ 1.48% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 4.32 | ★ 7.30 |
| Revenue | ★ $20,857,000,000.00 | $15,904,000,000.00 |
| Revenue This Year | $8.96 | $6.14 |
| Revenue Next Year | $4.72 | $5.35 |
| P/E Ratio | ★ $19.36 | $30.32 |
| Revenue Growth | ★ 7.44 | 3.85 |
| 52 Week Low | $65.15 | $134.65 |
| 52 Week High | $90.82 | $234.30 |
Technical Indicators
Market Signals| Indicator | CTSH | IQV |
|---|---|---|
| Relative Strength Index (RSI) | 80.08 | 53.84 |
| Support Level | $81.84 | $220.12 |
| Resistance Level | $84.87 | $226.77 |
| Average True Range (ATR) | 1.75 | 5.24 |
| MACD | 0.20 | -0.88 |
| Stochastic Oscillator | 94.81 | 54.94 |
Price Performance
Historical ComparisonAbout CTSH Cognizant Technology Solutions Corporation
Cognizant Technology Solutions is a multinational IT services provider that offers a range of consulting and business process outsourcing services. Originally founded in India, the company is headquartered in the US and serves enterprise customers spanning the financial services, healthcare, and resources industries. With most of its workforce located in India, Cognizant leverages a global delivery model that helps clients outsource their IT needs to offshore labor.
About IQV IQVIA Holdings Inc.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.